Unfit sufferers even have the alternative of venetoclax additionally obinutuzumab (VO) as frontline therapy. This is based over a period III demo that in contrast VO with ClbO in aged/unfit individuals.113 VO was superior concerning response level and development-absolutely free survival, and had a similar security profile. In this trial VO was adm… Read More